Our unique research approach (e.g., use of 9-TB) will facilitate future investigations into the role of airway epithelial NF-κB in respiratory infections of other strains of bacteria that are relevant to various lung diseases such as asthma, COPD and cystic fibrosis. Here, NFKB1 is linked to lung disorder.